Hannah Broadbent

Hannah Broadbent

Auto-generated profile, based on publicly available information

Hannah Broadbent

Centre for Brain and Cognitive Development, Birkbeck, University of London, London, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2011 in International Journal of Eating Disorders
Verified
Journal Article
Closed access
PDF file
HDHannah DeJong
Hannah DeJong
HBHannah Broadbent
Hannah Broadbent
USUlrike Schmidt
Ulrike Schmidt

1 January 2015 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Closed access
USUlrike Schmidt
Ulrike Schmidt
NMNicholas Magill
Nicholas Magill
BRBethany Renwick
Bethany Renwick
AKAlexandra Keyes
Alexandra Keyes
MKMartha Kenyon
Martha Kenyon
SLSabine Landau
Sabine Landau
Anorexia nervosa (AN) in adults has poor outcomes, and treatment evidence is limited. This study evaluated the efficacy and acceptability of a novel, targeted psychological therapy for AN (Maudsley Model of Anorexia Nervosa Treatment for Adults; MANTRA) compared with Specialist Supportive Clinical Management (SSCM). One hundred forty-two outpatients with broadly defined AN (body mass index [BMI] ≤ 18.5 kg/m²) were randomly allocated to receive 20 to 30 weekly sessions (depending on clinical severity) plus add-ons (4 follow-up sessions, optional sessions with dietician and with carers) of MANTRA (n = 72) or SSCM (n = 70). Assessments were administered blind to treatment condition at baseline, 6 months, and 12 months after randomization. The primary outcome was BMI at 12 months. Secondary outcomes included eating disorders symptomatology, other psychopathology, neuro-cognitive and social cognition, and acceptability. Additional service utilization was also assessed. Outcomes were analyzed using linear mixed models. Both treatments resulted in significant improvements in BMI and reductions in eating disorders symptomatology, distress levels, and clinical impairment over time, with no statistically significant difference between groups at either 6 or 12 months. Improvements in neuro-cognitive and social-cognitive measures over time were less consistent. One SSCM patient died. Compared with SSCM, MANTRA patients rated their treatment as significantly more acceptable and credible at 12 months. There was no significant difference between groups in additional service consumption. Both treatments appear to have value as first-line outpatient interventions for patients with broadly defined AN. Longer term outcomes remain to be evaluated.

3 November 2011 in European Eating Disorders Review
Verified
Journal Article
Closed access
PDF file
FEFrederique Van Den Eynde
Frederique Van Den Eynde
MSMasashi Suda
Masashi Suda
HBHannah Broadbent
Hannah Broadbent
SGSébastien Guillaume
Sébastien Guillaume
MEMagali Van Den Eynde
Magali Van Den Eynde
USUlrike Schmidt
Ulrike Schmidt

7 April 2011 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
PDF file
FEF. Van Den Eynde
F. Van Den Eynde
SGSébastien Guillaume
Sébastien Guillaume
HBH. Broadbent
H. Broadbent
DSDaniel Richard Stahl
Daniel Richard Stahl
ICI. C. Campbell
I. C. Campbell
KTKate Tchanturia
Kate Tchanturia

30 August 2011 in European Psychiatry
Verified
Journal Article
Closed access
FEF. Van Den Eynde
F. Van Den Eynde
SGSébastien Guillaume
Sébastien Guillaume
HBH. Broadbent
H. Broadbent
ICI.C. Campbell
I.C. Campbell
USU. Schmidt
U. Schmidt
The search for new treatments to improve outcome in people with anorexia nervosa continues. This pilot study investigated whether one session of high frequency repetitive transcranial magnetic stimulation (rTMS) delivered to the left dorsolateral prefrontal cortex reduces eating disorder related symptoms following exposure to visual and real food stimuli. Safety and tolerability were also assessed. Ten right-handed people with anorexia nervosa underwent one session of rTMS. Subjective experiences related to the eating disorder (e.g. urge to restrict, feeling full etc.) were assessed before and after rTMS. Non-parametric repeated measures tests were used. rTMS was safe and well-tolerated, and resulted in reduced levels of feeling full, feeling fat and feeling anxious. Thus, rTMS may reduce core symptoms of anorexia nervosa. Future research should establish the therapeutic potential of rTMS in anorexia nervosa.

26 November 2013 in Journal of Eating Disorders
Verified
Journal Article
Open access
PDF file
HDHannah DeJong
Hannah DeJong
AOAnna Oldershaw
Anna Oldershaw
LSLot Sternheim
Lot Sternheim
NSNelum Samarawickrema
Nelum Samarawickrema
MKMartha D Kenyon
Martha D Kenyon
USUlrike Schmidt
Ulrike Schmidt
Background: This study aimed to assess differences in Quality of Life (QoL) across eating disorder (ED) diagnoses, and to examine the relationship of QoL to specific clinical features.Results: 199 patients with a diagnosed ED completed the Clinical Impairment Assessment (CIA) [Cognitive Behavior Therapy and Eating Disorders, 315–318, 2008] and the Eating Disorders Examination (EDE) [Int J Eat Disord6:1–8]. Differences between diagnostic groups were examined, as were differences between restrictive and binge-purge subtypes.CIA scores and EDE scores were positively correlated and higher in groups with binge-purge behaviours. CIA scores were not correlated with BMI, illness duration or frequency of bingeing/purging behaviours, except in the binge-purge AN group, where CIA scores negatively correlated with BMI.Conclusions: Patients with EDs have poor QoL and impairment increases with illness severity. Patients with binge/purge diagnoses are particularly impaired. It remains unclear which clinical features best predict the degree of impairment experienced by patients with EDs.